目录 致谢 ................................................................................................................................................ iv 摘要 ...................................................................................................................................................... v 缩写表 ................................................................................................................................................ ix 符号表 ................................................................................................................................................ xi 图表表 ................................................................................................................................................ xiiii 表格表 ................................................................................................................................................ xix
A. 目录 �� ... ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������6 D. 首字母缩略词 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 E. 引言 ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������11 F. 参与和计划制定流程 ������������������������������������������������������������������������������������������������������������������������������������������������������17
页面摘要。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。iv 致谢。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。.v 目录。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。vi 图列表。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。ix 表格列表。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。xi 符号列表。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。xii 缩写列表。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。xiii
在此处给出了完整的确认部分:致谢:这项工作得到了中国国家自然科学基金会(No.62227801和No.UME20B2062,No.62376024)的支持,以及中国国家关键研究与发展计划(20222ZD0117900)。
致谢 ................................................................................................................ ii 摘要 ...................................................................................................................... iii 研究成果 ................................................................................................................ vi 目录 ...................................................................................................................... viii 表格列表 ...................................................................................................................... xii 图表列表 ...................................................................................................................... xiii 符号列表 ...................................................................................................................... xv 缩写列表 ............................................................................................................. xvii 第 1 章 简介 ...................................................................................................... 1
结论:已经开发了一种新型的Tofacitinib LC-MS/MS分析。探索了测量生化依从性的分析的影响。需要进一步的研究,以确定测定的敏感性和测定能力检测不遵守的能力。参考文献:[1] Alten R,KrügerK,Rellecke J,Schiffner-Rohe J,Behmer O,Schiffhorst G等。使用离散选择方法检查患者在类风湿关节炎治疗中的偏好。患者更喜欢依从性。2016; 10:2217-28。 [2] Suzuki M,Tse S,Hirai M,Kurebayashi Y. 将基于生理的药代动力学建模应用于日语预测tofacitinib的预测。 Kobe J Med Sci。 2017; 62(6):E150-E61。 Acknowledgements: Financial support was provided as an Investigator Spon- sored Research Grant from Pfizer Limited Disclosure of Interests: Stephanie Church Grant/research support from: Finan- cial support was provided as an Investigator Sponsored Research Grant from Pfizer Limited, Kimme Hyrich Speakers bureau: Honoraria as a speaker received from Abbvie, Grant/research support from: Financial support was provided as an Investigator Sponsored Research Grant from Pfizer 有限的。 AB在过去的12个月中获得了Scipher Medicine Ltd,Bristol Myers Squibb和Gal-Apagos的赠款。James Bluett Grant/Research Support in:Fanancial Support:Fanancial Support是作为调查员的PFISER LIM-IS提供的调查人员赞助研究赠款。 JB已从UCB,辉瑞和Eli Lilly Doi获得旅行/会议费:10.1136/Annrheumdis-2022-Eular.2422016; 10:2217-28。[2] Suzuki M,Tse S,Hirai M,Kurebayashi Y.将基于生理的药代动力学建模应用于日语预测tofacitinib的预测。Kobe J Med Sci。 2017; 62(6):E150-E61。 Acknowledgements: Financial support was provided as an Investigator Spon- sored Research Grant from Pfizer Limited Disclosure of Interests: Stephanie Church Grant/research support from: Finan- cial support was provided as an Investigator Sponsored Research Grant from Pfizer Limited, Kimme Hyrich Speakers bureau: Honoraria as a speaker received from Abbvie, Grant/research support from: Financial support was provided as an Investigator Sponsored Research Grant from Pfizer 有限的。 AB在过去的12个月中获得了Scipher Medicine Ltd,Bristol Myers Squibb和Gal-Apagos的赠款。James Bluett Grant/Research Support in:Fanancial Support:Fanancial Support是作为调查员的PFISER LIM-IS提供的调查人员赞助研究赠款。 JB已从UCB,辉瑞和Eli Lilly Doi获得旅行/会议费:10.1136/Annrheumdis-2022-Eular.242Kobe J Med Sci。2017; 62(6):E150-E61。 Acknowledgements: Financial support was provided as an Investigator Spon- sored Research Grant from Pfizer Limited Disclosure of Interests: Stephanie Church Grant/research support from: Finan- cial support was provided as an Investigator Sponsored Research Grant from Pfizer Limited, Kimme Hyrich Speakers bureau: Honoraria as a speaker received from Abbvie, Grant/research support from: Financial support was provided as an Investigator Sponsored Research Grant from Pfizer 有限的。 AB在过去的12个月中获得了Scipher Medicine Ltd,Bristol Myers Squibb和Gal-Apagos的赠款。James Bluett Grant/Research Support in:Fanancial Support:Fanancial Support是作为调查员的PFISER LIM-IS提供的调查人员赞助研究赠款。 JB已从UCB,辉瑞和Eli Lilly Doi获得旅行/会议费:10.1136/Annrheumdis-2022-Eular.2422017; 62(6):E150-E61。Acknowledgements: Financial support was provided as an Investigator Spon- sored Research Grant from Pfizer Limited Disclosure of Interests: Stephanie Church Grant/research support from: Finan- cial support was provided as an Investigator Sponsored Research Grant from Pfizer Limited, Kimme Hyrich Speakers bureau: Honoraria as a speaker received from Abbvie, Grant/research support from: Financial support was provided as an Investigator Sponsored Research Grant from Pfizer 有限的。AB在过去的12个月中获得了Scipher Medicine Ltd,Bristol Myers Squibb和Gal-Apagos的赠款。James Bluett Grant/Research Support in:Fanancial Support:Fanancial Support是作为调查员的PFISER LIM-IS提供的调查人员赞助研究赠款。JB已从UCB,辉瑞和Eli Lilly Doi获得旅行/会议费:10.1136/Annrheumdis-2022-Eular.242Research grant award from BMS, Kayode Ogungbenro Consultant of: Afferent, Biogen, Buzzard, Grant/research support from: Financial support was provided as an Investi- gator Sponsored Research Grant from Pfizer Limited., Richard Unwin Grant/research support from: Financial support was provided as an Investigator Sponsored Research Grant from Pfizer Limited, Anne Barton Grant/research support from: Financial support was provided as an Investigator Sponsored Research Grant from Pfizer 有限的。
前言 ................................................................................................................................................................ xv 致谢 ................................................................................................................................................................ xvi 本版新增内容 ................................................................................................................................................ xvi 如何使用学习功能 ...................................................................................................................................... xviii 如何使用在线资源 ...................................................................................................................................... xx 案例研究列表 ............................................................................................................................................. xxii 关于贡献者 ............................................................................................................................................. xxiv 世界地图 ...................................................................................................................................................... xxviii
1465 Gaurav Vermani† 导师:Aravind Machiry;Shashank Sharma;Ayushi Sharma † 演讲本科生作者;‡ 贡献本科生作者;* 本科生致谢在线摘要手册中列出的其他教职员工致谢。